Skip to main content

Table 2 Pre- and post-intervention data of sociodemographic, cardiovascular risk assessment and management in QPULSE

From: Findings and lessons learnt implementing a cardiovascular disease quality improvement program in Australian primary care: a mixed method evaluation

 

Pre-intervention

Post-intervention

Cardiovascular risk assessment

Total sample in 15 practices (n = 19,562)

Cardiovascular risk assessment

Total sample in 15 practices (n = 20,249)

Low/moderate (n = 8171)

High (n = 1139)

Established CVD (n = 2372)

Low/moderate (n = 9155)

High (n = 1195)

Established CVD (n = 2537)

Age (mean, SD)

61.1 (11.2)

72.4 (9.2)

73.6 (11.3)

63.9 (12.5)

60.8 (11.1)

71.9 (9.2)

73.5 (11.4)

63.8 (12.4)

Gender

 Male

38.2 (3124)

78.7 (896)

62.9 (1491)

44.6 (8717)

38.5 (3525)

78.4 (937)

61.8 (1569)

55.5 (11236)

 Female

61.8 (5047)

21.3 (243)

37.1 (879)

55.3 (10816)

61.5 (5630)

21.6 (258)

38.1 (967)

44.5 (9013)

 Missing

   

0.1 (29)

   

0.1 (13)

Ethnicity

 Aboriginal or Torres Strait Islander

0.4 (30)

0.5 (6)

0.3 (6)

0.4 (77)

0.4 (35)

0.7 (8)

0.5 (12)

0.5 (109)

 Other

99.6 (8141)

99.5 (1133)

99.7 (2366)

99.6 (19485)

99.6 (9120)

99.3 (1187)

99.5 (2525)

99.5 (20153)

Risk factor assessment

 Blood pressurea

81.9 (6690)

86.1 (981)

81.0 (1922)

72.5 (14175)

85.9 (7862)

93.0 (1111)

83.5 (2119)

76.4 (15487)

 Blood lipidsb

82.5 (6739)

82.0 (934)

70.7 (1678)

61.5 (12026)

85.0 (7781)

86.5 (1034)

75.5 (1916)

65.9 (13361)

 BMIb

54.6 (4460)

57.4 (654)

49.4 (1171)

45.0 (8814)

59.0 (5394)

65.4 (782)

45.1 (1347)

49.4 (10000)

 Waist circumferenceb

21.0 (1719)

25.3 (288)

15.9 (377)

15.6 (3039)

25.3 (2314)

32.4 (387)

19.9 (506)

34.7 (3952)

 Smoking status

63.2 (5164)

70.1 (798)

71.1 (1686)

65.3 (12774)

63.9 (5785)

65.3 (780)

66.8 (1695)

65.7 (13304)

BMI

 Underweight

3.2 (260)

1.1 (13)

2.1 (51)

2.5 (484)

3.4 (310)

0.8 (10)

2.6 (65)

2.7 (541)

 Healthy weight

21.6 (1768)

13.6 (155)

14.2 (336)

16.8 (3282)

23.1 (2114)

15.8 (189)

15.2 (386)

18.1 (3675)

 Overweight/obese

26.8 (2189)

34.3 (391)

26.9 (639)

22.8 (4467)

27.3 (2503)

31.5 (377)

27.9 (707)

23.6 (4786)

 Not assessed/missing

48.4 (3954)

50.9 (580)

56.7 (1346)

57.9 (11329)

46.2 (4228)

51.8 (619)

54.4 (1379)

55.6 (11260)

Waist circumference

 Normal

9.1 (741)

7.0 (80)

5.1 (122)

6.4 (1250)

11.4 (1047)

9.5 (113)

5.8 (148)

8.0 (1619)

 At riskc

22.5 (1840)

31.0 (353)

22.8 (541)

18.1 (3546)

26.2 (2398)

33.6 (402)

26.3 (666)

21.4 (4330)

 Not assessed/missing

68.4 (5590)

62.0 (706)

72.0 (1709)

75.5 (14766)

62.4 (5710)

56.9 (680)

67.9 (1723)

70.6 (14313)

Smoking status

 Never smoker

67.7 (5532)

43.3 (494)

48.8 (1157)

55.9 (10942)

68.4 (6260)

42.0 (502)

49.0 (1242)

57.6 (11673)

 Current smoker

22.1 (1808)

25.1 (286)

31.5 (747)

20.3 (3978)

22.2 (2028)

24.5 (293)

31.1 (789)

20.5 (4155)

 Ex-smoker

10.2 (831)

31.5 (359)

9.3 (220)

10.9 (2130)

9.5 (867)

33.5 (400)

9.8 (249)

10.9 (2211)

 Missing

  

10.5 (248)

12.8 (2512)

  

10.1 (257)

11.0 (2223)

CVD targets achieved

 Blood pressure

79.6 (5325)

20.7 (203)

42.2 (811)

67.8 (9609)

80.9 (6360)

20.5 (228)

46.1 (976)

68.4 (10586)

 Total cholesterol

11.4 (769)

22.7 (212)

53.9 (904)

20.5 (2462)

11.3 (877)

24.7 (255)

52.5 (1006)

20.3 (2708)

 LDL cholesterol

13.9 (938)

26.0 (243)

55.2 (926)

25.0 (3010)

13.9 (1080)

25.8 (267)

54.5 (1043)

24.6 (3282)

 HDL cholesterol

92.5 (6234)

73.4 (686)

78.7 (1320)

86.7 (10418)

93.0 (7240)

73.2 (757)

80.1 (1534)

86.6 (11698)

Prescribed BP- and lipid-lowering medicationsd

16.6 (1357)

42.5 (484)

69.8 (1656)

25.1 (4901)

16.0 (1464)

44.1 (527)

68.9 (1748)

25.2 (5096)

  1. aAssessed in the past 12 months
  2. bAssessed in the past 2 years
  3. c‘At risk’ waist circumference > 94 cm for males and > 80 cm for females
  4. dGuideline-recommended treatment was defined as [1] For high-risk patients the prescription of a BP-lowering medication and a statin [5]; for patients with established CVD, prescription of a BP-lowering medication, a statin and either an antiplatelet or an anticoagulant agent (see Appendix 1 for specific medications)